Innovation in Endobronchial Sampling
- Conditions
- Diffuse Interstitial Lung Disease
- Interventions
- Procedure: Advanced endoscopic imaging modalities
- Registration Number
- NCT02380326
- Lead Sponsor
- KU Leuven
- Brief Summary
Evaluating an integrated diagnostic work-up of virtual navigation bronchoscopy (VNB), confocal laser endomicroscopy and micro computerized tomography (micro-CT) in the diagnostic path of pulmonary lesions in the non-oncological patient.
- Detailed Description
The region(s) of interest that has/have to be sampled, will be selected upfront. Guided by the endobronchial pathway that is created by virtual bronchoscopy, the flexible bronchoscope will be navigated to the regions of interest and an optical biopsy of the region will be obtained using pCLE. One biopsy sample will be processed in the endoscopy suite to be able to prepare it for micro-CT analysis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Presence of diffuse pulmonary disease necessitating bronchoscopic evaluation.
- Informed consent available
- Age > 18
- FVC > 50%pred
- DLCO > 35%pred
- PaO2 > 55 mmHg, pCO2 < 45 mmHg (ambient air)
- No exclusion criteria
- Age > 75
- Systolic arterial pressure in the pulmonary artery : PAPS >40mmHg
- Platelet count <100000/µl
- INR > 1.4
- BMI >30
- Diffuse bullous lung disease
- Active anti-platelet or anticoagulant treatment
- Active heart failure or unstable coronary heart disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Diffuse intersitial lung disease Advanced endoscopic imaging modalities Patients suffering from diffuse intersitial lung disease without a certain diagnosis subjected to advanced endoscopic imaging modalities Lung transplant recipients Advanced endoscopic imaging modalities Lung transplant recipients with diffuse parenchymal abnormalities subjected to advanced endoscopic imaging modalities
- Primary Outcome Measures
Name Time Method Diagnostic yield postprocedural
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UZ Leuven
🇧🇪Leuven, Belgium